Xia Wang

Radiology
677 N Wilmot Rd
Tucson, AZ 85711

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.

CD161⁺ NKT Cell Proportion as a Predictive Biomarker for Bortezomib Treatment Response in Newly Diagnosed Multiple Myeloma Patients.

Journal: Clinical laboratory
Published: May 20, 2026
Showing 1-1 of 1

Last Updated: 09/26/2026